Quince Therapeutics, Inc. , a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases, announced that the U.S. Patent and ...

January 31, 2025 expert reaction to NICE final draft guidance on exagamglogene autotemcel (exa-cel) for severe sickle cell disease . Scientists comment on final draft guidance fro ...

Vertex Pharmaceuticals (Nasdaq: VRTX) announced today a reimbursement agreement with NHS England for eligible sickle cell disease (SCD) patients to access the CRISPR/Cas9 gene-edited therapy, CASGEVY® ...

Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the National Institute for Health and Care Excellence (NICE) said on Friday. The ...

Researchers studying gene expression have access to vast amounts of data from cells or tissues. This is thanks to advances in ...

Dr. Eric Verdin studies the biology of aging and how our lifestyle can extend our quality of life. Vitamin D is among the supplements he uses regularly.

NIH grant funds immersive program to give M.D., Ph.D. postdoctoral fellows hands-on training in cancer drug development Ph.D.

SOUTH SAN FRANCISCO - Cytokinetics , Incorporated (NASDAQ:CYTK), a $5.7 billion biopharmaceutical company, has announced the awarding of $100,000 in grants to five patient advocacy organizations ...

Diet Coke is having a moment as the drink of choice for Donald Trump, but daily consumption may carry risks, including ...

The strategy paid off, with RBC’s team in position to pitch the acquisition of Hostess to New York Stock Exchange-listed Smuckers, positioning its team of bankers as the lead financial adviser on the ...

While major Canadian banks aren’t usually known for offering the highest returns, especially when compared to other Schedule 1 banks, RBC has recently offered competitive rates for those looking ...